Effectiveness of ivermectin in rats with haloperidol induced tardive dyskinesia.
Article Sidebar
Main Article Content
Introduction: Extrapiramidal symptoms and tardive dyskinesia are common problems associated with antypsychotic therapy. Basic and clinical research is warranted due to the lack of effective therapies aimed to the prevention and treatment of antipsychotic side effects.
Objective: To evaluate the effect of ivermectin in rats with haloperidol induced tardive dyskinesia.
Methods: The effect of ivermectin on motor behavior and abnormal movements was tested in Sprague-Dawley rats treated with a single dose of haloperidol. In addition, a chronic animal model known as VCM (vacuous chewing movements) was implemented with the objective to evaluate the effect of ivermectin on the frequency of orofacial movements during a period of six months.
Results: Ivermectin does not prevent the motor behavior and frequency of abnormal movements induced by haloperidol in the acute model. Orofacial movements were not reduced with ivermectin in the chronic model. In addition, ivermectin was not associated with changes in motor behavior and abnormal movements in the acute and chronic model.
Conclusions: Ivermectin is not a good candidate for the treatment of tardive dyskinesia and the results of this study do not support the GABAergic hypothesis in the physiopathology of tardive dyskinesia. Additionally, ivermectin does not induce abnormal movements.
Objective: To evaluate the effect of ivermectin in rats with haloperidol induced tardive dyskinesia.
Methods: The effect of ivermectin on motor behavior and abnormal movements was tested in Sprague-Dawley rats treated with a single dose of haloperidol. In addition, a chronic animal model known as VCM (vacuous chewing movements) was implemented with the objective to evaluate the effect of ivermectin on the frequency of orofacial movements during a period of six months.
Results: Ivermectin does not prevent the motor behavior and frequency of abnormal movements induced by haloperidol in the acute model. Orofacial movements were not reduced with ivermectin in the chronic model. In addition, ivermectin was not associated with changes in motor behavior and abnormal movements in the acute and chronic model.
Conclusions: Ivermectin is not a good candidate for the treatment of tardive dyskinesia and the results of this study do not support the GABAergic hypothesis in the physiopathology of tardive dyskinesia. Additionally, ivermectin does not induce abnormal movements.
- Haloperidol
- Ivermectin
- Dyskinesia drug induced
- Antipsychotic agents
Palacios, M., & Pimienta, H. (2008). Effectiveness of ivermectin in rats with haloperidol induced tardive dyskinesia. Colombia Medica, 39(3.Supl.3), 71–77. https://doi.org/10.25100/cm.v39i3Supl3.608
Downloads
Download data is not yet available.
- Jorge Hernán Ramírez, Mauricio Palacios, Oscar Gutiérrez, Estudio del efecto antihipertensivo de la Salvia scutellarioides en un modelo de ratas hipertensas. , Colombia Medica: Vol. 37 No. 1 (2006)
- David Riascos, Francisco Guzmán, Efraín Buriticá, Mauricio Palacios, Martha Isabel Escobar, Hernán Pimienta, Organotypic human neuronal culture derived from traumatic brain injury. , Colombia Medica: Vol. 39 No. 3.Supl.3 (2008): Neurociencias
- Jorge Hernán Ramírez, Mauricio Palacios, Hugo Hernán Ocampo, Claudia Zuluaga, Oscar Gutiérrez, Lack of association between blood pressure, target organ damage and retinopathy in the L-NAME rat hypertension model: Are new animal models of hypertension required?. , Colombia Medica: Vol. 37 No. 4 (2006)
- Mauricio Palacios, Jorge Hernán Ramírez, Clinical trials registration and the «instead of» research phenomenon. , Colombia Medica: Vol. 38 No. 1 (2007)
- Luis Carlos López, Marcela Botero, Jaime Pino, Jorge Hernán Ramírez, Mauricio Palacios, Adverse drug reactions in internal medicine units at a university hospital: A descriptive pilot study , Colombia Medica: Vol. 41 No. 1 (2010)
- Germán Gabriel Castillo, Harry Mauricio Pachajoa, Sandra Eliana Villota, Edwin Zurita, Mauricio Palacios, Oscar Gutiérrez, Study of the gastric acid anti-secretory activity of Cannabis sativa in an animal model. , Colombia Medica: Vol. 37 No. 4 (2006)
- Martha Isabel Escobar, Francisco Guzmán, Efraín Buriticá, David Riascos, Liliana Villamil, Hernán Pimienta, Changes in laminar and dendritic organization of the cerebral cortex after traumatic brain injury. , Colombia Medica: Vol. 39 No. 3.Supl.3 (2008): Neurociencias
- Jorge Hernán Ramírez, Mauricio Palacios, Oscar Gutiérrez, Implementation of the isolated vascular tissue model as a device for the validation of medicinal plants: Study of the vasodilator activity of Salvia scutellarioides. , Colombia Medica: Vol. 38 No. 1 (2007)
- Mauricio Palacios, Las Buenas Prácticas Clínicas en Colombia. , Colombia Medica: Vol. 39 No. 4 (2008)
- César A. Arango Dávila, Martha Isabel Escobar, Efraín Buriticá, Hernán Pimienta, Exofocal changes in experimental focal cerebral ischemia: an experimental approach and its clinical correlation. , Colombia Medica: Vol. 39 No. 3.Supl.3 (2008): Neurociencias
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use